Xtant Medical Q1 Earnings Call Highlights
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
Xtant Medical Reports First Quarter 2026 Financial Results
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
Xtant Medical Finalizes Companion Spine Transactions
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
AWM Investment Company Inc. Takes $4.88 Million Position in Xtant Medical Holdings, Inc. $XTNT
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine
Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
Xtant Medical Reports Third Quarter 2025 Financial Results
Xtant Medical Announces Commercial Launch of CollagenX™
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
Xtant Medical Reports Second Quarter 2025 Financial Results
Xtant Medical to Attend the CG 45th Annual Growth Conference
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine
Xtant Medical Announces the Launch of OsteoFactor Pro™
Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript
Xtant Medical Reports First Quarter 2025 Financial Results
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript
Xtant Medical Reports Third Quarter 2024 Financial Results
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call Transcript
Xtant Medical Announces Closing of $5.0 Million Private Placement
Xtant Medical Announces $5.0 Million Private Placement
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Xtant Medical Holdings, Inc. (XTNT) Q1 2024 Earnings Call Transcript
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds